ARCHIVES

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

March 15, 1991

NCI Approved Clinical Trials

May 28, 2010

DRCA Planning Described; New Cancer Control Conference Set

February 4, 1983

NCI New Advisory Group Named On special Populations

June 25, 1999

Tobacco Control In The States Can Reduce Use, NCPB Says.

February 18, 2000

Project Expands Group Studies To Community Oncologists.

March 10, 2000